NEW YORK, Sept. 21, 2015 /PRNewswire/ -- Changes in the pharmaceutical industry may be driving companies to prescription pharmaceutical drugs where demand is stronger. So says a report from market researcher Kalorama Information. The firm said companies need to get creative in an environment of financial difficulty and patent losses for the pharmaceutical industry. Kalorama made its estimate in its latest report, World Market for Prescription Dermatological Drugs, 9th Edition (Anti-acne, Anti-aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments).
The pharmaceutical industry is facing a tougher environment in general, due to harder regulations for gaining approvals for mainstream products, economic issues, and a dwindling pipeline of new products.
"Reliance on blockbuster drugs is all but over, causing a shift of focus for many drug research and development entities," said Bruce Carlson, Publisher of Kalorama Information. "By focusing on cosmetic medications, many manufacturers are realizing less scrutiny from the FDA and a growing need in the niche markets such as dermatology."
Kalorama thinks this transition will play a role in the future development of the dermatological industry over the next five years. The worldwide pharmaceutical sector has little choice but to continue expanding through mergers and acquisitions for some time to come. The sector is ripe for the picking, too, with the financial crisis having created an impressive buyer's market for larger companies, as smaller firms struggle to extend financing.
"True globalization of pharmaceuticals has arrived," Carlson said. "Most of the growth in the next few years will be outside the US, Europe and Japan. It's a very dynamic time for the industry focusing on a worldwide market."
Kalorama found that the worldwide market for prescription dermatological products reached $21.2 billion in 2015, nearly eight percent growth since two years ago. Specific growth rates are detailed in Kalorama Information's report. The report also details the market size for various categories of prescription dermatological drugs, describes the worldwide market for prescription dermatological drugs, and identifies major market factors that may help to shape the worldwide market for prescription dermatological drugs in the future. Market for Prescription Dermatological Drugs, 9th Edition can be found at: http://www.kaloramainformation.com/redirect.asp?progid=87807&productid=9251725.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.
We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.
Contact:
Bruce Carlson
(212) 807-2622
[email protected]
www.KaloramaInformation.com
Logo - http://photos.prnewswire.com/prnh/20150831/262422LOGO
SOURCE Kalorama Information
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article